₹1,899.50
₹-22.50 (-1.17%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹4,56,114 Cr
P/E
37.64
ROE
13.74%
ROCE
17.33%
About Sun Pharmaceutical Industries Ltd
Sun Pharmaceuticals Industries is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulation and Active Pharmaceutical ingredients.
Founded
1993
CEO
Dilip S Shanghvi
Employees
28,925
HQ
Mumbai, India
About Sun Pharmaceutical Industries Ltd
Sun Pharmaceuticals Industries is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulation and Active Pharmaceutical ingredients.
Founded:1993
CEO:Dilip S Shanghvi
Employees:28,925
HQ:Mumbai, India
Finished Products
1Sale of Products
₹92,585.33Cr2Other Operating Revenue
₹1,149.84CrRaw Materials
1Raw Material
₹13,658.91Cr2Purchase of Traded Goods
₹4,994.06Cr3Packing /Other Materials
₹4,429.38CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹2,047
52W Low
₹1,548
Volume648.85K
Avg VolumeN/A
Beta0.49
Dividend Yield0.84%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
37.64x
Valuation
P/B Ratio
5.46x
Valuation
EPS
₹50.50
Valuation
Dividend Yield
0.84%
Valuation
ROE
13.74%
Profitability
ROCE
17.33%
Profitability
Revenue by Segment
Contribution & growth by business line
PharmaceuticalsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
33.8%
International
66.2%
India33.8%
United States of America30.3%
Emerging markets20.1%
Rest of the world15.8%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.06x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
6.4%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.